Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATORVASTATIN Cause Myocardial infarction? 1,093 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 1,093 reports of Myocardial infarction have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 1.4% of all adverse event reports for ATORVASTATIN.

1,093
Reports of Myocardial infarction with ATORVASTATIN
1.4%
of all ATORVASTATIN reports
83
Deaths
560
Hospitalizations

How Dangerous Is Myocardial infarction From ATORVASTATIN?

Of the 1,093 reports, 83 (7.6%) resulted in death, 560 (51.2%) required hospitalization, and 52 (4.8%) were considered life-threatening.

Is Myocardial infarction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 1,093 reports have been filed with the FAERS database.

What Other Side Effects Does ATORVASTATIN Cause?

Type 2 diabetes mellitus (7,556) Myalgia (7,155) Drug hypersensitivity (3,929) Drug ineffective (3,865) Fatigue (3,439) Arthralgia (3,338) Rhabdomyolysis (3,286) Dyspnoea (3,137) Nausea (2,888) Asthenia (2,791)

What Other Drugs Cause Myocardial infarction?

ROSIGLITAZONE (17,018) TESTOSTERONE (3,396) ADALIMUMAB (3,214) SACUBITRIL\VALSARTAN (3,120) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391) APIXABAN (2,010) TICAGRELOR (1,749) LENALIDOMIDE (1,712) ETANERCEPT (1,693) METFORMIN\ROSIGLITAZONE (1,640)

Which ATORVASTATIN Alternatives Have Lower Myocardial infarction Risk?

ATORVASTATIN vs ATORVASTATIN\EZETIMIBE ATORVASTATIN vs ATOSIBAN ATORVASTATIN vs ATOVAQUONE ATORVASTATIN vs ATOVAQUONE\PROGUANIL ATORVASTATIN vs ATRACURIUM

Related Pages

ATORVASTATIN Full Profile All Myocardial infarction Reports All Drugs Causing Myocardial infarction ATORVASTATIN Demographics